Furthermore, the targeted inhibition of AKT1 and AKT3 prevented glycolysis-related enzyme activation, significantly blocked the production of lactate and diminished the migration and invasion of chemoresistant colon cancer cells [25]. Here, AKT3 is linked to malignant colon neoplasm.